Dr. Michael R Simon, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 36 Malaga Cove Plz, Suite #310, Palos Verdes Estates, CA 90274 Phone: 310-375-8888 Fax: 310-375-7883 |
Dr. Michael H Park, DDS Dentist - Pediatric Dentistry Medicare: Medicare Enrolled Practice Location: 702 Via Del Monte, Palos Verdes Estates, CA 90274 Phone: 224-595-9132 |
Dr. Richard David Benner, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 36 Malaga Cove Plz, Palos Verdes Estates, CA 90274 Phone: 310-375-8888 Fax: 310-375-7883 |
Dr. Michael Schultz, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2109 Via Visalia, Palos Verdes Estates, CA 90274 Phone: 310-378-0182 |
Mansoureh Soltani, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 841 Via Somonte, Palos Verdes Estates, CA 90274 Phone: 310-916-5683 |
Seongsu Kang Dentist Medicare: Not Enrolled in Medicare Practice Location: 2121 Palos Verdes Dr W, Palos Verdes Estates, CA 90274 Phone: 310-749-1291 |
Dr. Andrew Ghadimi, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2736 Via Miguel, Palos Verdes Estates, CA 90274 Phone: 310-591-9244 |
Dr. Kevin M. Ehtessabian, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2725 Via Victoria, Palos Verdes Estates, CA 90274 Phone: 310-308-5996 |
Dr. Dyan Marie Vandevelde, DMD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 2325 Palos Verdes Dr W Ste 210, Palos Verdes Estates, CA 90274 Phone: 310-377-6580 Fax: 310-377-3838 |
News Archive
The U.S. Food and drug Administration (FDA) has finally approved AstraZeneca's Brilinta blood thinner for patients with acute coronary syndrome - conditions, such as heart attack and angina.
Even as state officials decide whether they will set up online insurance markets or allow the Obama administration to do it for them, some wonder if the federal government is up to the task. Decisions about the health law's Medicaid expansion are also on governors' minds.
Researchers at the Commerce Department's National Institute of Standards and Technology (NIST) and Cornell University have capitalized on a process for manufacturing integrated circuits at the nanometer (billionth of a meter) level and used it to develop a method for engineering the first-ever nanoscale fluidic (nanofluidic) device with complex three-dimensional surfaces.
Researchers from the Schepens Eye Research Institute of Massachusetts Eye and Ear have shown that a slight increase in transforming growth factor beta (TGF-β), which is present in preclinical animal models with diabetic eye disease, protects retinal blood vessels from damage that commonly occurs in the early stages of the disease.
› Verified 9 days ago